tyrosyl-prolyl-tryptophyl-glycinamide and naloxonazine

tyrosyl-prolyl-tryptophyl-glycinamide has been researched along with naloxonazine in 2 studies

Compound Research Comparison

Studies (tyrosyl-prolyl-tryptophyl-glycinamide)	Trials (tyrosyl-prolyl-tryptophyl-glycinamide)	Recent Studies (post-2010) (tyrosyl-prolyl-tryptophyl-glycinamide)	Studies (naloxonazine)	Trials (naloxonazine)	Recent Studies (post-2010) (naloxonazine)
25	0	0	200	0	30

Protein Interaction Comparison

Protein	Taxonomy	naloxonazine (IC50)
Mu-type opioid receptor	Homo sapiens (human)	0.0072
Delta-type opioid receptor	Homo sapiens (human)	0.136
Kappa-type opioid receptor	Homo sapiens (human)	0.085

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujimura, T; Ito, K; Kawamura, S; Mizoguchi, H; Murayama, K; Nakayama, D; Sakurada, C; Sakurada, S; Sakurada, T; Sato, T; Watanabe, C; Watanabe, H	1
Mizoguchi, H; Nakayama, D; Sakurada, S; Sakurada, T; Watanabe, C; Watanabe, H	1

Other Studies

2 other study(ies) available for tyrosyl-prolyl-tryptophyl-glycinamide and naloxonazine

Article	Year
A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse. The Journal of pharmacology and experimental therapeutics, 2005, Volume: 312, Issue:3 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Animals; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Male; Mice; MSH Release-Inhibiting Hormone; Naloxone; Naltrexone; Narcotic Antagonists; Oligopeptides; Receptors, Opioid, mu	2005
A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors. European journal of pharmacology, 2007, Jun-01, Volume: 563, Issue:1-3 Topics: Analgesics, Opioid; Animals; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Hot Temperature; Injections, Intraventricular; Male; Mice; MSH Release-Inhibiting Hormone; Naloxone; Narcotic Antagonists; Oligopeptides; Pain; Pain Measurement; Pain Threshold; Reaction Time; Receptors, Opioid, mu; Somatostatin; Time Factors	2007

Article

Year

A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.

The Journal of pharmacology and experimental therapeutics, 2005, Volume: 312, Issue:3

Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Animals; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Male; Mice; MSH Release-Inhibiting Hormone; Naloxone; Naltrexone; Narcotic Antagonists; Oligopeptides; Receptors, Opioid, mu

2005

A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.

European journal of pharmacology, 2007, Jun-01, Volume: 563, Issue:1-3

Topics: Analgesics, Opioid; Animals; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Hot Temperature; Injections, Intraventricular; Male; Mice; MSH Release-Inhibiting Hormone; Naloxone; Narcotic Antagonists; Oligopeptides; Pain; Pain Measurement; Pain Threshold; Reaction Time; Receptors, Opioid, mu; Somatostatin; Time Factors

2007